Table 1.
Immunization schedule in China in 2016.
| Recommended age at administration |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vaccine | Birth | 1 m | 2 m | 3 m | 4 m | 5 m | 6 m | 8 m | 9 m | 18 m | 2 y | 3 y | 4 y | 5 y | 6 y |
| Expanded Program on Immunization (EPI) vaccines | |||||||||||||||
| HepB | 1 | 2 | 3 | ||||||||||||
| BCG | 1 | ||||||||||||||
| IPV | 1 | ||||||||||||||
| OPV | 1 | 2 | 3 | ||||||||||||
| DTaP | 1 | 2 | 3 | 4 | |||||||||||
| DT | 1 | ||||||||||||||
| MR | 1 | ||||||||||||||
| MMR | 1 | ||||||||||||||
| JE-live or JE-inactivated |
1 | 2 | |||||||||||||
| 1, 2 | 3 | 4 | |||||||||||||
| MPSV-A | 1 | 2 | |||||||||||||
| MPSV-AC | 1 | 2 | |||||||||||||
| HepA-live or HepA-inactivated | 1 | ||||||||||||||
| 1 | 2 | ||||||||||||||
| Non-EPI vaccinesa | |||||||||||||||
| Hib | 1 | 2 | |||||||||||||
| PCV | 1 | 2 | 3 | ||||||||||||
| Influenza | 1 | 2 | |||||||||||||
| Rotavirus | 1 | ||||||||||||||
| PPSV | 1 | ||||||||||||||
| Varicella | 1 | ||||||||||||||
BCG: bacillus Calmette–Guérin, DT: diphtheria-tetanus, DTaP: diphtheria-tetanus-acellular pertussis, HepA: hepatitis A (2BS cell strains), HepB: hepatitis B (recombinant Hansenula polymorpha), IPV: inactivated polio vaccine (Types I, II, and III), JE: Japanese encephalitis (SA14-14-2 strains), MMR: measles-mumps-rubella vaccine (measles: Shanghai-191, mumps: vS79 Strains, rubella: BRD Ⅱ), MPSV: meningococcal polysaccharide vaccine (Group A & C), MR: measles-rubella vaccine (measles: Shanghai-191, rubella: BRD Ⅱ), OPV: oral polio vaccine (Types I; and III), PCV: pneumococcal conjugate vaccine (13 valent), PPSV: pneumococcal polysaccharide vaccine (23 valent), rotavirus (Lanzhou lamb rotavirus or Rotarix).
aNon-EPI vaccines are administered according to manufacturer’s instructions, without official guidance from the China Experts Advisory Committee on Immunization Program.